Modified Glasgow Prognostic Score is predictive of prognosis for non-small cell lung cancer patients treated with stereotactic body radiation therapy: a retrospective study.

J Radiat Res · 2021 · PMC8127692 · PMID 33866376

Europe PMC DOI

hedged sentences

0.1490

closest p · 3.0× alpha

0.1490

boldest claim

The sentences

showed a trendP = 0.149not close (p > 0.1)

The data showed a trend that patients with high mGPS suffered earlier progression compared to those with low mGPS (54.3 vs 88.1 months, P = 0.149).

also in 53,322 other papers

a strong trendno p-value reported

Although, no significant difference was found between the subgroups in TTP (54.3 vs 88.1 months, P = 0.149), the data showed a strong trend that patients with a high mGPS suffered an early progression in about 2.8 years.

also in 5,725 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.